Medical Weight Management (Physician-Led Care)

Semaglutide and tirzepatide are prescription medications that may be used as part of a physician-directed medical weight management plan for select patients. These medications work on metabolic and appetite-regulating pathways in the body and are prescribed only when medically appropriate.

At Renuva, all medical weight management care is physician-led. Medications are not prescribed automatically and are offered only after a good-faith medical examination, review of health history, and clinical assessment confirm that a patient is an appropriate candidate. Treatment decisions are made solely by the supervising physician and are based on safety, medical necessity, and current clinical guidelines.

These medications are not suitable for everyone and require ongoing medical oversight, follow-up, and monitoring. Participation is individualized, voluntary, and part of a broader medical care plan.

Find Out If You Qualify

Understanding the Differences

Both semaglutide and tirzepatide are injectable prescription medications used in medical weight management, but they act on the body in different ways.

Tirzepatide acts on two metabolic pathways related to appetite regulation and blood sugar control. Because of this dual mechanism, it may be considered for different patient needs depending on clinical assessment and physician judgment.

Neither medication is universally appropriate, and selection is based on medical evaluation, risk factors, tolerance, and physician discretion. Results and experiences vary, and no outcomes are guaranteed.